Novartis has announced a massive investment in manufacturing and R&D facilities in the US, including seven new facilities, in ...

The top-line results of the APOLLOE4 trial showed that valitramiprosate (ALZ-801) was unable to slow down cognitive decline ...

The oral drug – Johnson & Johnson's Balversa (erdafitinib) – will become an option for adults with metastatic or unresectable ...

For Reuters Pharma Europe 2025, pharmaphorum is providing coverage courtesy NAVLIN Daily, a pricing and market access ...

Top NHS doctor, CEO out. Across the pond, NHS England is also seeing big changes with Sir Stephen Powis announcing his plans ...

AKT inhibitor Truqap (capivasertib) has been cleared by NICE for use in combination with standard therapy fulvestrant for ...

Robert F Kennedy Jr's controversial views on vaccines were on display this week during an interview with CBS News in which he ...

Incyte's infringement lawsuit is claiming that Sun Pharma's drug infringes a US patent (No. 9,662,335) it holds on the use of ...

Since 1938, animal testing has been required by the FDA before any new drug can proceed through clinical trials and receive ...

A notice posted by the NIH in February said the agency would slash its funding of indirect costs borne by research teams at ...

EVERSANA has added another feature to its ORCHESTRATE platform for the commercialisation of life science products – an ...